Navigation Links
Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrig's Disease (ALS)
Date:6/23/2011

nts are based upon current beliefs, expectations and assumptions and are subject to a number of risks and uncertainties, many of which are difficult to predict and include statements regarding the planned Phase llb clinical trial, the ability to conduct the clinical trial under an IND application, the suggested role of zinc in the treatment of  ALS, the planned primary and secondary endpoints and the anticipated number of clinical trial centers and enrolled patients. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from those reflected in Adeona's forward-looking statements include, among others, our failure to obtain regulatory approval or market approval of the use of AEN-100 and AEN-200 in the treatment of ALS, failure to obtain approval to conduct the trial under the IND , failure of the clinical trial evaluating AEN-100 and AEN-200 to have favorable result such as  a failure to show benefits of zinc therapy in ALS patients, a failure of the treatment group to have a decrease in toxicity from unbound glutamate or a  failure of ALS patients treated with our proprietary zinc to successfully meet the planned primary and secondary endpoints,  and other factors described in Adeona's report on Form 10-K for the year ended December 31, 2010 and any other filings with the SEC. The information in this release is provided only as of the date of this release, and Adeona undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.


'/>"/>
SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Adeona Announces HartLab Expansion Into Microbiology Testing Services
2. Adeona Completes Equity Financing and Provides Alzheimers Disease Clinical Study Update
3. Adeona Announces Second Quarter 2010 Profitability and Achievements
4. Adeona Announces Five Scientific Publications on Role of Copper Toxicity and Zinc Deficiency in Alzheimers Disease and Cognitive Decline
5. Adeona CEO to Provide Keynote Address at the 2010 MichBio Expo & Conference Emerging Biosciences Showcase
6. Adeona to Hold Annual Shareholder Meeting
7. Adeona Announces Third Quarter 2010 Financial Results and Achievements
8. Adeona Acquires Access to Clinical Data Supporting Oral Zinc for Prevention of Infections in the Elderly
9. Adeona to Present at OneMedForum San Francisco 2011 Conference
10. Adeona to Host Investor Day on Zinc Deficiency in Alzheimers Disease
11. Adeona to Raise $4 Million in Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... ALBANY, New York , July 25, 2014 /PRNewswire/ ... published by Transparency Market Research "Global and China Insulin ... Insulin) - Industry Analysis, Size, Share, Growth, Trends and ... insulin market was valued at USD 19.99 billion in ... of 6.1% from 2013 to 2019 to reach USD ...
(Date:7/25/2014)... July 25, 2014  IDEXX Laboratories, Inc. (NASDAQ: ... second quarter of 2014 increased 11% versus the prior ... for the second quarter of 2014 versus the ... changes in distributor inventory 2 . Earnings per diluted ... increased 11% from the prior year period to $1.10."In ...
(Date:7/25/2014)... Leading events organizer UBM Live announces ... seventh year to São Paulo, Brazil ... The event will co-locate with Food Ingredients South America (FiSA), ... point for the pharmaceutical industry.      (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a) ... sales are now exploring the South America ...
Breaking Medicine Technology:Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 2Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 3Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 4IDEXX Laboratories Announces Second Quarter Results 2IDEXX Laboratories Announces Second Quarter Results 3IDEXX Laboratories Announces Second Quarter Results 4IDEXX Laboratories Announces Second Quarter Results 5IDEXX Laboratories Announces Second Quarter Results 6IDEXX Laboratories Announces Second Quarter Results 7IDEXX Laboratories Announces Second Quarter Results 8IDEXX Laboratories Announces Second Quarter Results 9IDEXX Laboratories Announces Second Quarter Results 10IDEXX Laboratories Announces Second Quarter Results 11IDEXX Laboratories Announces Second Quarter Results 12IDEXX Laboratories Announces Second Quarter Results 13IDEXX Laboratories Announces Second Quarter Results 14IDEXX Laboratories Announces Second Quarter Results 15IDEXX Laboratories Announces Second Quarter Results 16IDEXX Laboratories Announces Second Quarter Results 17IDEXX Laboratories Announces Second Quarter Results 18IDEXX Laboratories Announces Second Quarter Results 19IDEXX Laboratories Announces Second Quarter Results 20IDEXX Laboratories Announces Second Quarter Results 21IDEXX Laboratories Announces Second Quarter Results 22IDEXX Laboratories Announces Second Quarter Results 23IDEXX Laboratories Announces Second Quarter Results 24IDEXX Laboratories Announces Second Quarter Results 25IDEXX Laboratories Announces Second Quarter Results 26IDEXX Laboratories Announces Second Quarter Results 27IDEXX Laboratories Announces Second Quarter Results 28IDEXX Laboratories Announces Second Quarter Results 29IDEXX Laboratories Announces Second Quarter Results 30IDEXX Laboratories Announces Second Quarter Results 31IDEXX Laboratories Announces Second Quarter Results 32IDEXX Laboratories Announces Second Quarter Results 33
(Date:7/25/2014)... 25, 2014 As thousands of transvaginal ... courts, Bernstein Liebhard LLP notes that the Food & ... consumer advocacy group, Public Citizen, to order a global ... dated May 1, 2014, and released to the public ... for a ban on the marketing of all surgical ...
(Date:7/25/2014)... 2014 (HealthDay News) -- Babies seem to learn even ... the time women are 34 weeks pregnant, their unborn ... voice reciting a familiar nursery rhyme, the researchers report. ... sensory stimulation in the developing fetus," Charlene Krueger, nursing ... College of Nursing, said in a university news release. ...
(Date:7/25/2014)... vulnerable neurons and reduce motor deficits in a ... University School of Medicine have shown. , The ... Parkinson,s Disease . , The findings demonstrate that ... at sufficient levels and have beneficial effects when ... Previous studies of XPro1595 in animals tested more ...
(Date:7/25/2014)... American Society of Anesthesiologists (ASA) today announced the ... Learning Collaborative, a national initiative designed to improve ... More than 40 leading health care organizations ... collaborative, which will convene for the first time ... 25-26, in Schaumburg, Ill. , The PSH collaborative ...
(Date:7/25/2014)... 2014 Parkulture is proud ... and parkour instructor, Jared “JJ” Woods, will be competing ... American Ninja Warrior. The show will premiere on local ... will rerun on the new Esquire Network on Tuesday, ... resident, has been balancing careers as a professional stuntman ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 4Health News:Rhymes Reveal Evidence of Learning in the Womb 2Health News:Anti-inflammatory drug can prevent neuron loss in Parkinson's model 2Health News:ASA launches national Perioperative Surgical Home learning collaborative 2Health News:ASA launches national Perioperative Surgical Home learning collaborative 3Health News:Jared “JJ” Woods Prepares for American Ninja Warrior City Finals 2Health News:Jared “JJ” Woods Prepares for American Ninja Warrior City Finals 3
... Td-Vac priced at Rs. 7.50 has been launched by Serum ... aimed at combating the fatal tetanus and diphtheria (Td) in ... existing dual antigen vaccine used in children and would be ... administered following injury. ,The vaccine is regarded to ...
... which costs US$ 2,300 is used for heart diseases, and ... likely to result // in allergic reactions, the risks ... ,The Northwestern Memorial Hospital’s Dr. Charles Davidson has ... limited. The new drug-eluting stents are Cypher and Taxus. There ...
... been devised that can predict the potential attack of asthma.// ... help to asthmatics control their symptoms more effectively and improve the ... of an asthma attack occurring over the next month was made ... the model is the chaos model. The model the international team ...
... measure of how fast a person can exhale can now ... before a month using a mathematical tool. //It is believed ... patients and lead to the development of better treatment strategies. ... (currently applied to complex systems such as weather) has been ...
... Government promised in June last year that every patient referral ... 'choose and book' system by the end // of this ... the latest month for which figures are available - barely ... ,The Department of Health figures show that between October 2004 ...
... leading vaccine manufacturer Serum Institute of India has manufactured for ... // . ,The vaccine is called Td-Vac and ... and adults. The new vaccine will replace the existing TT ... ,Td-Vac is priced at Rs 7.50 whereas the TT vaccine ...
Cached Medicine News:Health News:Mathematical Model Can Now Help Predict Asthma Risk 2Health News:GP's online referral scheme in UK 'a national IT disaster' 2
... Ordering/Dispensing has gained recognition as the industry ... system. It enables opticians to place instant ... electronic communications technology. When used in conjunction ... frame tracers, lens shapes are automatically transmitted ...
... complete practice and business management software ... and ophthalmologists- It is designed for ... graphically rich and intuitive windows interface ... features and functionality- The multi-user version ...
The K-4500 automated hematology analyzer offers fast reliable test results of 18-parameter plus 3-histograms, valuable for effective diagnosis....
The XT-2000i is a compact, high performance, automated hematology analyzer that provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test re...
Medicine Products: